Literature DB >> 8520921

[Phytotherapeutic aspects of diseases of the cardiovascular system. 5. Saponins and possibilities of their use in prevention and therapy].

J Purmová1, L Opletal.   

Abstract

The summarizing paper deals with the structure and biological effects of saponins generally and in relation with the treatment and prevention of diseases of the heart and circulatory system. In this field, mainly the saponins from the plants of the genera Panax, Gynostemma or Bupleurum are of use. Also soya saponins and saponins of the genera Astragalus, Salvia, Boussigaultia and Litchi can be employed. Saponins exert a positive effect on the function of the heart direct, or they help treat related diseases. For instance, they inhibit the formation of lipid peroxides in the cardiac muscle or in the liver, they influence the function of enzymes contained in them, they decrease blood coagulation, cholesterol and sugar levels in blood, they stimulate the immunity system. They act either direct, blocking the transfer of Ca2+ ions or modulating the function of Na(+)-K(+)-ATPase, or they help resorb other active principles. It can be concluded that saponins are a prospective group of drugs of natural origin for the prevention and treatment of diseases of the heart and circulatory system.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8520921

Source DB:  PubMed          Journal:  Ceska Slov Farm        ISSN: 1210-7816


  3 in total

1.  Anti-cancer effect and the underlying mechanisms of gypenosides on human colorectal cancer SW-480 cells.

Authors:  Han Yan; Xiaobing Wang; Junfeng Niu; Yaqin Wang; Pan Wang; Quanhong Liu
Journal:  PLoS One       Date:  2014-04-21       Impact factor: 3.240

Review 2.  Anti-cancer effects of Gynostemma pentaphyllum (Thunb.) Makino (Jiaogulan).

Authors:  Yantao Li; Wanjun Lin; Jiajun Huang; Ying Xie; Wenzhe Ma
Journal:  Chin Med       Date:  2016-09-27       Impact factor: 5.455

3.  Gypenosides induce cell death and alter gene expression in human oral cancer HSC-3 cells.

Authors:  Kung-Wen Lu; Yi-Shih Ma; Fu-Shun Yu; Yi-Ping Huang; Yung-Lin Chu; Rick Sai-Chuen Wu; Ching-Lung Liao; Fu-Shin Chueh; Jing-Gung Chung
Journal:  Exp Ther Med       Date:  2017-07-25       Impact factor: 2.447

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.